Search results
A Dodgers fan guide to Citi Field, home of the New York Mets
True Blue LA· 2 hours agoA Dodgers fan’s review of Citi Field in Queens, New York, the stadium where the Mets play their home...
Chapman's heroic defensive effort seals another Giants comeback win
NBC Sports BayArea via Yahoo Sports· 2 hours agoMatt Chapman's defensive heroic's secured yet another thrilling Giants comeback in San Francisco's...
Pinduoduo's Q1 growth driven by strong transactions; Citi reaffirms stock as buy By Investing.com
Investing.com· 3 days agoOn Wednesday, Citi reaffirmed its Buy rating on Pinduoduo Inc. (NASDAQ:PDD), maintaining a $185.00...
Citi fined £62m after ‘fat finger’ trade triggered £1.1bn share sale
Daily Telegraph· 3 days agoCiti has been fined £62m by UK regulators after a “fat finger” trade triggered a flash crash on the...
Citi fined $79 million by UK regulators over 'fat-finger' failures
Reuters via Yahoo Finance· 3 days agoLONDON (Reuters) -UK regulators fined Citigroup 61.6 million pounds ($78.5 million) for controls...
Citi Isn’t the Only One With a Fat Finger Problem
The Wall Street Journal· 22 hours ago“I’m slower following the Reddit hiveminds into trades, and if I do, I’m exercising more caution,” he said. “I’m double-checking myself and...
Citi fined $78.4M over 2022 flash crash error
Banking Dive via Yahoo Finance· 3 days agoA Citi trader had meant to sell a basket of equities at $58 million but mistakenly created a $444 billion basket, regulators said. About $189 billion of...
Citi cuts ULTA Salon stock target, maintains neutral rating By Investing.com
Investing.com· 1 day agoOn Friday, Citi adjusted its outlook on ULTA Salon (NASDAQ: ULTA), reducing the stock's price target...
Citi Rewards+ Card review: Good for rewards newbies who don’t mind a learning curve
Yahoo Personal Finance· 2 days agoRewards credit cards are increasingly popular as people look for ways to get more value from their...
Citi maintains neutral on Arrowhead, price target at $29 By Investing.com
Investing.com· 5 days agoOn Monday, Citi reiterated a Neutral rating on Arrowhead Pharma (NASDAQ:ARWR), with a consistent...